Location: Home
  • search
  • go
  • Relate News
  • 10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
  • 10/3/2023CNIPA Invalides Novo's Core Chinese Patent for Semaglutide as Petition...
  • 10/3/2023As Another New Normal of China Healthcare Dawns, Pharma MNCs Need to C...
  • 9/29/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/29/2023CDE Solicits Comments on the Technical Guidelines for the Study of Ove...
  • 9/29/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/29/2023Recent Executive Moves
  • 9/29/2023Drug R&D and Product Registration News Digest 09/2023 (4)
  • 9/29/2023Financial-related Company News Digest (September 2023)
  • 9/29/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...
  • 9/28/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/28/2023CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...
  • 9/28/2023CDE Issues on the Technical Guidelines for Clinical Trials of Dry Eye ...
  • 9/28/2023CDE Issues on the Technical Guidelines for Clinical Trials of Multiple...
  • 9/28/2023CDE Issues on the Technical Guidelines for Clinical Trials of Lupus Ne...
  • 9/28/2023CDE Issues on the Technical Guidelines for Clinical Trials of Drugs fo...
  • 9/28/2023Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
  • 9/27/2023CDE Issues the Technical Guidelines for Non-clinical Research of Antib...
  • 9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...
  • 9/26/2023China Becomes Country with Highest and Increasingly Younger Alzheimer ...
  • 9/26/2023CDE Solicits Comments on the Technical Guidelines for the Assessment o...
  • 9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...
  • 9/26/2023Control Dispute with Hengrui Led to Dissolution Drama of Reistone Biop...
  • 9/26/2023Chinese Patents of Four MNC Originator Drugs Face Imminent Invalidatio...
  • 9/26/2023WuXi Debuts First Vaccine CDMO Site in China
  • 9/26/2023Patent Linkage In China: What The First Decisions Reveal About The Dir...
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/25/2023CDE Solicits Comments on the Acceptance and Review Guide to GQCE Studi...
  • 9/25/2023CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • Page:103/790 Total number of articles:23678: [First][<<] [101] [102] [103] [104] [105] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group